Aardvark Therapeutics, Inc.

AARDCIK 0001774857 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 23, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0166Δ-0.000789% similar+535/-571 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 14, 2026no items parsed May 7, 2026no items parsed Mar 24, 2026no items parsed Mar 23, 2026no items parsed Feb 27, 2026no items parsed

YoY shift: Neutral

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.07pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Aardvark Therapeutics, Inc.

Name	Roles	Filings
Lee Tien-Li	OfficerDirector10% Owner	8
Sun Nelson	Officer	5
Chi Jeffrey	Director	2
Jaiman Manasi	Officer	2
Jones Bryan	Officer	2

Showing 1-5 of 16

Per pagePage 1 of 4Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Aardvark Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Lee Tien-Li	7	71%	+32.1%	+45.4%	+81.7%	-66.7%
2	Sun Nelson	3	33%	-7.9%	-31.7%	+74.7%	-66.7%

All filings

25 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Feb 11, 2026	Jaiman Manasi Chief Medical Officer	Holdings only	-	-	-
Feb 11, 2026	Lee Tien-Li Chief Executive Officer · Director · 10% Owner	Holdings only	-	-	-
Feb 11, 2026	Sun Nelson Chief Financial Officer	Holdings only	-	-	-
Dec 12, 2025	Lee Tien-Li Chief Executive Officer · Director · 10% Owner	PPurchase	7,000	$14.485	$101,395
Dec 12, 2025	Sun Nelson Chief Financial Officer	PPurchase	3,000	$14.40	$43,200

Showing 1-5 of 25

Per pagePage 1 of 5Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value